Supplementary Figure 6: Further characterization of the role of ZFP36L1 in the regulation of the SASP.
From: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

(a) GSEAs of a signature associated with senescence60 and (left) SASP components upregulated in OIS (ref. 6; right) in the gene expression profile (GEP) of IMR90 ER:RAS cells expressing ZFP36L1Mut versus control IMR90 ER:RAS, both 4OHT-treated. NES, normalized enrichment score; FDR, false discovery rate. GEPs were obtained by performing transcriptome sequencing (RNA-Seq) of the aforementioned conditions in n = 3 independent experiments. RNAs were collected 7 days after induction with 4OHT. (b) Mean ARE score of genes down regulated (at the indicated log2 of fold changes) when comparing IMR90 ER:RAS cells expressing ZFP36L1Mut versus control IMR90 ER:RAS, are shown in blue. The distribution of mean ARE scores derived from 105 simulations of random genes with equal sample size are shown in red. (c) This is an extension of Fig. 6c. The expression of TIMP was monitored by qRT-PCR at the indicated times. Data are for a representative experiment of n = 2 independent experiments. (d) Brdu incorporation was measured by IF at the indicated times. Error bars represent the ±s.d. from n = 3 independent experiments. Student’s t-test was performed to compare ZFP36L1Mut expressing cells (200 ng ml−1 doxycycline) to the control senescent cells (vector, +4OHT). ***P < 0.001. (e,f) IMR90 ER:RAS expressing TRE–FLAG-ZFP36L1Mut (or empty vector) and the reverse transactivator (rtTA-M3) were further infected with a vector encoding the coding sequence of p21. After 6 days of incubation with 4OHT, the expression of ZFP36L1Mut was induced with 200 ng ml−1 doxycycline for 72 h and (e) the % of BrdU positive cells or (f) SA-β-Gal positive cells was quantified. Error bars represent the ±s.d. from n = 4 independent experiments. SA-β-Gal stainings are representative of n = 3 independent experiments. Student’s t-test was performed to compare the indicated conditions ***P < 0.001; NS, non significant. For raw data, see Supplementary Table 7.